23 May 2024
McKesson, Merck back Atropos Health’s $30M round to accelerate drug development with AI - 2024-05-23 22:08:10Z
Title:McKesson, Merck back Atropos Health's $30M round to accelerate drug development with AI Summary: Atropos Health raises $30 million in Series B funding to revolutionize healthcare with AI-powered clinical evidence generation, aiming to personalize medical decision-making and accelerate drug development. Link: McKesson, Merck back Atropos Health's $30M round to accelerate drug development with AI
